The neoantigen field is rapidly evolving with drug developers around the world racing to make best-in-class neoantigen therapeutics and vaccines. To achieve this, leading experts are looking for service providers with capabilities in manufacturing, translational services, peptide services, sequencing, assay services and bioinformatics to enhance the production and development of both personalised and shared neoantigen derived therapeutics and vaccines.
This summit is your opportunity to communicate exciting progress to the decision-makers in the field, generate leads, and understand what tools and services the market wants and needs. You can rely on our ability to advise and deliver the right opportunities for you.
If you offer relevant services and want to maximise your companies exposure, contact us today to discuss your bespoke commercial package at the 7th International Neoantigen Summit.
Benefit from Market Intelligence
Hear how and where pharmaceutical companies are looking for services and solutions to facilitate their R&D to match your solutions accordingly
Meet & Network In-Person with Industry Pioneers
With a room full of drug developers, meet prospective clients during speed networking breaks and informal networking receptions to fuel commercial opportunities
Position Yourself as an Industry Expert
With the growing landscape of Neoantigen-based biotech companies, this meeting a dedicated platform to put your independent expertise in front of the key decision-makers in the field
Raise Brand Awareness & Generate Commercial Collaborations
Benefit from pre and post conference exposure to our key opinion leaders and make sure you connect with the hottest prospects
If you offer relevant services and would like to align your company within the Neoantigen space, contact us to discuss a bespoke commercial package to promote your brand at the 7th International Neoantigen Summit.
Hear Why This Year’s Speakers Are Excited for the Conference:
“I believe collaboration is key to overcoming challenges in developing innovative therapies for cancer. Specialized meetings that brings together diverse group of people working towards the same goal is a great forum to further collaboration and speed up drug development.”
- Erkut Bahceci, Chief Medical Officer, BlueSphere Bio
“The Neoantigen Summit offers the invaluable opportunity of meeting other experts in the immune oncology space, both from academia and industry. We’re happy to exchange ideas and opinions with the rich community at the meeting.”
– Maarten Slagter & Jeroen Kneppers, Scientists (Computational) Cancer Genomics, CureVac
“The Neoantigen Summit will be a great chance to interact with other players in the field and exchange ideas for the benefit of improved patient healthcare.”
– Martin Löwer, Deputy Director Biomarker Development, TRON
“Significant improvements in the breadth and sensitivity of technologies able to identify and validate novel classes of cancer antigens are yielding innovative and complementary approaches to therapeutic development. Shared learnings will allow the field to leverage potential synergies and partnerships to fully exploit these advancements.”
– Wayne Paes, Senior Scientist, Grey Wolf Therapeutics